2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Clinical and morphometric features of the tics

S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)

Tics/Stereotypies  ·  Hall 3FG

1:45pm-3:15pm

Clinical characteristics of turkish patients with Parkinson’s disease: A retrospective analysis of 428 patients

B. Gonenli Kocer, E. Ozturk, S. Comoglu (Ankara, Turkey)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Clinical characterization of Pramipexole induced edema and skin reaction in Parkinson’s Disease (PD) after one year of follow up

E. Urrea-Mendoza, N. Rincon, F. Revilla (Greenville, SC, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Clinical characterization of tremor in patients with Phenylketonuria (PKU)

F. Nardecchia, F. Manti, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG

1:45pm-3:15pm

Clinical effectiveness of a highly challenging balance training (HiBalance program) for Parkinson’s disease: A multi-center clinical effectiveness trial

B. Leavy, C. Joseph, N. Löfgren, H. Johansson, M. Hagströmer, E. Franzén (Stockholm, Sweden)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Clinical practice of levodopa in parkinsonism

AC. Chen (Taichung, Taiwan)

Neuropharmacology  ·  Hall 3FG

1:45pm-3:15pm

Clinical profile and predictors of outcome in Neuroleptic malignant syndrome and Parkinsonism hyperpyrexia syndrome

R. Kandadai, P. Dutta, S. Meka, T. Syed, S. Tandra, S. Turaga, R. Borgohain (Hyderabad, India)

Drug-Induced Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Clinical study on the correlation between Parkinson’s somatosensory evoked potentials and STN-DBS parameters

Z. Jing, Y. Xiaoxue, G. Shuzhao, S. Chunli, L. Zhanhua, (Dalian, China)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Clinical trial protocol: Restitution of oral transport, penetration and aspiration with nigral stimulation in Parkinson’s disease?

A. Schoellmann, L. Stoll, B. Hobl, C. Meisner, A. Gharabaghi, D. (Tuebingen, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation (CLOVER-DBS)

F. Sasaki, G. Oyama, S. Sekimoto, R. Nakamura, T. Jo, H. Iwamuro, A. Umemura, Y. Shimo, N. Hattori (Tokyo, Japan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG